Alembic Pharmaceuticals reports 65% rise in Q2 consolidated net profit

22 Oct 2018 Evaluate

Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2018.

The company has reported over 2 fold jump in its net profit at Rs 251.06 crore for the quarter under review as compared to Rs 122.10 crore for the same quarter in the previous year. Total income of the company increased by 42.60% at Rs 1,097.44 crore for Q2FY19 as compared Rs 769.62 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 64.59% in its net profit after taxes, non-controlling interests and share of profit of associates and joint ventures at Rs 200.07 crore for the quarter under review as compared to Rs 121.56 crore for the same quarter in the previous year. Total income of the company increased by 41.72% at Rs 1,129.43 crore for Q2FY19 as compared Rs 796.96 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

852.30 -4.95 (-0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×